Andrew Arno insider trades
Open-market stock purchases and sales by Andrew Arno, Director at Insight Molecular Diagnostics Inc, from SEC Form 4 filings since Jul 27, 2011.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +75%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | IMDX Insight Molecular Diagnostics Inc | Bought (not open market) | — |
| Mar 26, 2026 | VTAK Catheter Precision, Inc | Bought (not open market) | — |
| Mar 9, 2026 | SMSI Smith Micro Software, Inc | Bought (not open market) | — |
| Nov 10, 2025 | XXII 22nd Century Group, Inc | Bought (not open market) | — |
| Nov 10, 2025 | XXII 22nd Century Group, Inc | Bought (not open market) | — |
| Oct 9, 2025 | SMSI Smith Micro Software, Inc | Bought (not open market) | — |
Companies traded
- IMDX Insight Molecular Diagnostics Inc: other filings, last Jun 11, 2026
- VTAK Catheter Precision, Inc: other filings, last Mar 26, 2026
- SMSI Smith Micro Software, Inc: 5 buys, last Mar 9, 2026
- XXII 22nd Century Group, Inc: 1 buy, last Nov 10, 2025
- OCX Oncocyte Corp: 8 buys, last Dec 26, 2024
- AST Asterias Biotherapeutics, Inc: 1 buy, last Jun 21, 2018